Contingent vulnerability of entorhinal parvalbumin-containing neurons in Alzheimer's disease

Journal of Neuroscience

Volumn 16, Issue 10, 1996, Pages 3311-3321

  Solodkin, Ana ^a   Veldhuizen, Stacy D ^a   Van Hoesen, Gary W ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Alzheimer's disease; calcium binding proteins; entorhinal cortex; GABA; parahippocampal gyrus; parvalbumin immunohistochemistry

Indexed keywords

4 AMINOBUTYRIC ACID; CALCIUM BINDING PROTEIN; PARVALBUMIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENTORHINAL CORTEX; HIPPOCAMPUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NEUROFIBRILLARY TANGLE; NEUROPIL; PRIORITY JOURNAL; SUBICULUM;

EID: 0029930270     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.16-10-03311.1996     Document Type: Article

References (79)

1. Akiyama H, McGeer PL, Itagaki S, McGeer EG, Kaneko T (1989) Loss of glutaminase-positive cortical neurons in Alzheimer's disease. Neurochem Res 14:353-358.
2. Andressen C, Blümcke Celio MR (1993) Calcium binding proteins: selective markers of nerve cells. Cell Tissue Res 271:181-208.
3. Arai H, Emson PC, Mountjoy CQ, Carrasco LH, Heizmann CW (1987) Loss of parvalbumin immunoreactive neurons from cortex in Alzheimer's disease dementia. Brain Res 418:164-169.
4. Arnold SE, Hyman BT, Flory J, Damasio AR, Van Hoesen GW (1991) The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cereb Cortex 1:103-116.
5. Auchus AP, Green RC, Nemeroff CB (1994) Cortical and subcortical neuropeptides in Alzheimer's disease. Neurobiol Aging 15:589-595.
6. Baimbridge JG, Celio MR, Rogers JH (1992) Calcium-binding proteins in the nervous system. Trends Neurosci 15:303-308.
7. Beall MJ, Lewis DA (1992) Heterogeneity of layer II neurons in human entorhinal cortex. J Comp Neurol 321:241-266.
8. Braak H, Braak E (1991) Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 82:239-259.
9. Braak H, Braak E (1992) The human entorhinal cortex: normal morphology and laminar-specific pathology in various diseases. Neurosci Res 15:6-31.
10. Braak E, Strotkamp B, Braak H (1991) Parvalbumin-immunoreactive structures in the hippocampus of the human adult. Cell Tissue Res 264:33-48.
11. Celio MR (1986) Parvalbumin in most gamma-aminobutyric-acid-containing neurons of the cat cerebral cortex. Science 231:995-997.
12. Celio MR (1990) Calbindin D-28k and parvalbumin in the rat nervous system. Neuroscience 35:375-475.
13. Cellerino A, Siciliano R, Domenici L, Maffei L (1992) Parvalbumin immunoreactivity: a reliable marker for the effects of monocular deprivation in the rat visual cortex. Neuroscience 51:749-753.
14. Chandrasekaran K, Giordano T, Brady DR, Stoll J, Martin LJ, Rapoport SI (1994) Impairment in mitochondrial cytochrome oxidase gene expression in Alzheimer's disease. Mol Brain Res 24:336-340.
15. 28K and parvalbumin in rat sensory neurons. J Physiol (Lond) 472:341-357.
16. Davies P, Maloney AJR (1976) Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 2:1403.
17. De Jong GI, Van der Zee EA, Bohus B, Luiten PGM (1993) Reversed alterations of hippocampal parvalbumin and protein kinase C-γ immunoreactivity after stroke in spontaneously hypertensive stroke-prone rats. Stroke 24:2082-2086.
18. DeFelipe J, Hendry SHC, Jones EG (1989) Visualization of chandelier cell axons by parvalbumin immunoreactivity in the monkey cerebral cortex. Proc Natl Acad Sci USA 86:2093-2097.
19. DeFelipe J, Garcia Sola R, Marco P, del Rio MR, Pulido P, Ramon y Cajal S (1993) Selective changes in the microorganization of the human epileptogenic neocortex revealed by parvalbumin immunoreactivity. Cereb Cortex 3:39-48.
20. Demeulemeester H, Arckens L, Vandesande F, Orban GA, Heizmann CW, Pochet R (1991) Calcium-binding proteins and neuropeptides as molecular markers of GABAergic interneurons in the cat visual cortex. Exp Brain Res 84:538-544.
21. Ferrer I, Soriano E, Tuñon T, Fonseca M, Guionnet N (1991) Parvalbumin immunoreactive neurons in normal human temporal neocortex and in patients with Alzheimer's disease. J Neurol Sci 106:135-141.
22. Ferrer I, Casas R, Rivera R (1993) Parvalbumin-immunoreactive cortical neurons in Creutzfeldt-Jakob's disease. Ann Neurol 34:864-866.
23. Fonseca M, Soriano E, Ferrer I, Martinez A, Tuñon T (1993) Chandelier cell axons identified by parvalbumin-immunoreactivity in the normal human temporal cortex and in Alzheimer's disease. Neuroscience 55:1107-1116.
24. Geula C, Mesulam M-M (1989) Cortical cholinergic fibers in aging and Alzheimer's disease: a morphometric study. Neuroscience 33:469-481.
25. Giacobini E (1990) Cholinergic receptors in human brain: effects of aging and Alzheimer's disease. J Neurosci Res 27:548-560.
26. Goedert M, Spillantini MG, Jakes R (1991) Localization of the Alz-50 epitope in recombinant human microtubule-associated protein Tau. Neurosci Lett 126:149-154.
27. Hansen LA, DeTeresa R, Davies P, Terry RD (1988) Neocortical morphometry, lesion counts and choline acetyltransferase levels in the age spectrum of Alzheimer's disease. Neurology 38:48-54.
28. Heinsen H, Henn R, Eisenmenger W, Gotz M, Bohl J, Bethke B, Lockemann U, Püschel K (1994) Quantitative investigations on the human entorhinal cortex areas: left-right asymmetry and age-related changes. Anat Embryol 190:181-194.
29. 2+-binding proteins in human neurodegenerative disorders. Trends Neurosci 15:259-264.
30. Hendry SHC, Jones EG, Emson PC, Lawson DEM, Heizmann CW, Streit P (1989) Two classes of cortical GABA neurons defined by differential calcium-binding protein immunoreactivities. Exp Brain Res 76:467-472.
31. Hof PR, Morrison JH (1991) Neocortical neuronal subpopulations labeled by a monoclonal antibody to calbindin exhibit differential vulnerability in Alzheimer's disease. Exp Neurol 111:293-301.
32. Hof PR, Cox K, Young WG, Celio MR, Rogers J, Morrison JH (1991) Parvalbumin-immunoreactive neurons in the neocortex are resistant to degeneration in Alzheimer's disease. J Neuropathol Exp Neurol 50:451-462.
33. Hof PR, Nimchinsky EA, Celio MR, Bouras C, Morrison JH (1993) Calretinin-immunoreactive neocortical interneurons are unaffected in Alzheimer's disease. Neurosci Lett 152:145-149.
34. Hyman BT, Gomez-Isla T (1994) Alzheimer's disease is a laminar, regional and neural system specific disease, not a global brain disease. Neurobiol Aging 15:353-354.
35. Hyman BT, Van Hoesen GW, Damasio AR, Barnes CL (1984) Alzheimer's disease: cell specific pathology isolates the hippocampal formation. Science 225:1168-1170.
36. Hyman BT, Van Hoesen GW, Damasio AR (1987) Alzheimer's disease: glutamate depletion in the hippocampal perforant pathway zone. Ann Neurol 22:37-40.
37. Inaguma Y, Shinohara H, Inagaki T, Kato K (1992) Immunoreactive parvalbumin concentrations in patients with Alzheimer's disease. J Neurol Sci 110:57-61.
38. Insausti R, Tuñon T, Sobreviela T, Insausti AM, Gonzalo LM (1995) The human entorhinal cortex: a cytoarchitectonic analysis. J Comp Neurol 355:171-198.
39. Iwamoto N, Emson PC (1991) Demonstration of neurofibrillary tangles in parvalbumin-immunoreactive interneurons in the cerebral cortex of Alzheimer-type dementia brain. Neurosci Lett 128:81-84.
40. Jaarsma D, Veenma-van der Duin L, Korf J (1994) N-acetylaspartate and N-acetylaspatylglutamate grades in Alzheimer's disease post-mortem brain tissue. J Neurol Sci 127:230-233.
41. Johansen FF, Tonder N, Zimmer J, Baimbridge KG, Diemer NH (1990) Short term changes of parvalbumin and calbindin immunoreactivity in the rat hippocampus following cerebral ischemia. Neurosci Lett 120:171-174.
42. Kalaria RN (1993) The immunopathology of Alzheimer's disease and some related disorders. Brain Pathol 3:333-347.
43. Khachaturian ZS (1985) Diagnosis of Alzheimer's disease. Arch Neurol 42:1097-1105.
44. Khachaturian ZS, Cotman CW, Pettegrew JW (1989) Calcium, membranes, aging and Alzheimer's disease. Ann NY Acad Sci 568:1-292.
45. 2+-binding protein parvalbumin in the rat hippocampus and dentate gyrus. Brain Res 419:119-130.
46. Lewis DA, Lund JS (1990) Heterogeneity of chandelier neurons in monkey neocortex: corticotropin-releasing factor and parvalbumin-immunoreactive populations. J Comp Neurol 293:599-615.
47. Lorente de Nó R (1933) Studies on the structure of the cerebral cortex. J Psychol Neurol 45:381-438.
48. Lowe SL, Bowen DM, Francis PT, Neary D (1990) Ante mortem cerebral amino acid concentrations indicate selective degeneration of glutamate-enriched neurons in Alzheimer's disease. Neuroscience 38:571-577.
49. Masliah E, Mallory M, DeTeresa R, Alford M, Hansen L (1993) Differing patterns of aberrant neuronal sprouting in Alzheimer's disease with and without Lewy bodies. Brain Res 617:258-266.
50. Mattson MP (1994) Calcium and neuronal injury in Alzheimer's disease: contributions of beta-amyloid precursor protein mismetabolism, free radicals and metabolic compromise. Ann NY Acad Sci 747:50-76.
51. McGeer PL, Kawamata T, Walker DG, Akiyama H, Tooyama I, McGeer EG (1993) Microglia in degenerative neurological disease. Glia 7:84-92.
52. Mirra SS, Heyman A, McKeel D, Sumi SM, Grain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L (1991) The consortium to establish a registry for Alzheimer's disease (CERAD). II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41:479-486.
53. Mizutani T, Shimada H (1992) Neuropathological background of twenty-seven centenarian brains. J Neurol Sci 108:168-177.
54. Morrison JH, Lewis DA, Campbell MJ, Huntley GW, Benson DL, Bouras C (1987) A monoclonal antibody to non-phosphorylated neurofilament protein marks the vulnerable cortical neurons in Alzheimer's disease. Brain Res 416:331-336.
55. Mufson EJ, Brandabur MM (1994) Sparing of NADPH-diaphorase striatal neurons in Parkinson's and Alzheimer's diseases. NeuroReport 5:705-708.
56. Nitsch R, Frotscher M (1993) Transneuronal changes in dendrites of GABAergic parvalbumin-containing neurons of the rat fascia dentata following entorhinal lesion. Hippocampus 3:481-490.
57. Omidi K, Hendry SHC, Jones EG, Emson PC (1988) Organization of plasticity of GABA neuronal subpopulation in monkey area 17, defined by differential coexistence of calcium-binding proteins. Soc Neurosci Abstr 14:780.
58. Palmer AM, DeKosky ST (1993) Monoamine neurons in aging and Alzheimer's disease. J Neural Transm [GenSect] 91:135-159.
59. Perry EK, Perry RH, Blessed G, Tomlison BE (1977) Necropsy evidence of central cholinergic deficits in senile dementia. Lancet 1:89.
60. Pike CI, Cotman CW (1995) Calretinin-immunoreactive neurons are resistant to β-amyloid toxicity in vitro. Brain Res 671:293-298.
61. Price DL, Koliatsos VE, Sisodia SS, Koo EH, Martin LJ, Walker LC, Applegate MD, Cork LC (1991) Amyloid-related proteins and nerve growth factor in Alzheimer's disease and animal models. Clin Neuropharmacol 14[Suppl 1]:S9-S14.
62. Satoh J, Tabira T, Sano M, Nakayama H, Tateishi J (1991) Parvalbumin-immunoreactive neurons in the human central nervous system are decreased in Alzheimer's disease. Acta Neuropathol 81:388-395.
63. Schmidt-Kastner R, Meller D, Eysel UT (1992) Immunohistochemical changes of neuronal calcium-binding proteins parvalbumin and calbindin-D-28k following unilateral differentiation in the rat visual system. Exp Neurol 117:230-246.
64. Scott SA, Mufson EJ, Weingartner JA, Skau KA, Crutcher KA (1995) Nerve growth factor in Alzheimer's disease: increased levels throughout the brain coupled with declines in nucleus basalis. J Neurosci 15:6213-6221.
65. Solodkin A, Van Hoesen GW (1993) Calcium-binding proteins on the human parahippocampal gyrus and their alterations in Alzheimer's disease. Soc Neurosci Abstr 19:191.
66. Solodkin A, Van Hoesen GW (1996) The entorhinal cortex modules of the human brain. J Comp Neurol 365:1-18.
67. +) nigrat toxicity in the rat by prior decortication of MK-801 treatment: a stereological estimate of neuronal loss. Neurobiol Aging 14:295-301.
68. Su JH, Anderson AJ, Cummings BJ, Cotman CW (1994) Immunohistochemical evidence for apoptosis in Alzheimer's disease. NeuroReport 5:2529-2533.
69. Terry RD, Masliah E, Salmon DP, Butters N, De Teresa R, Hill R, Hansen LA, Katzman R (1991) Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 30:572-580.
70. Tortosa A, Ferrer I (1993) Parvalbumin immunoreactivity in the hippocampus of the gerbil after transient forebrain ischemia: a qualitative and quantitative study. Neuroscience 55:33-43.
71. Trillo L, Gonzalo LM (1993) Ageing of the human entorhinal cortex and subicular complex. Histol Histopathol 7:17-22.
72. Tun̄ón T, Insausti R, Ferrer I, Sobreviela T, Soriano E (1992) Parvalbumin and calbindin D-28K in the human entorhinal cortex: an immunohistochemical study. Brain Res 589:24-32.
73. VanBrederode JF, Mulligan KA, Hendrickson AE (1990) Calcium-binding proteins as markers for subpopulations of GABAergic neurons in monkey striate cortex. J Comp Neurol 298:1-22.
74. Van Hoesen GW, Solodkin A (1993) Some modular features of temporal cortex in humans as revealed by pathological changes in Alzheimer's disease. Cereb Cortex 3:465-475.
75. Van Hoesen GW, Solodkin A (1994) Cellular and systems neuroanatomical changes in Alzheimer's disease. In: Calcium hypothesis of aging and dementia, Vol 747 (Disterhoft JF, Khachaturian ZS, eds), pp 12-35. New York: New York Academy of Science.
76. West MJ (1994) Regionally specific loss of neurons in the human aging hippocampus. Neurobiol Aging 14:287-293.
77. West MJ, Coleman PD, Flood DG, Troncoso JC (1994) Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease. Lancet 344:769-772.
78. Whitehouse PJ, Price DL, Clark AW, Coyle JT, DeLong MR (1981) Alzheimer's disease: evidence for a selective loss of cholinergic neurons in the nucleus basalis. Ann Neurol 10:122-126.
79. Zhan SS, Kamphorst W, Van Nostrand WE, Eikelenboom P (1995) Distribution of neuronal growth factor-promoting factors and cytoskeletal proteins in altered neurites in Alzheimer's disease and non-demented elderly. Acta Neuropathol 89:356-362.